Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials

Overview of attention for article published in Frontiers in oncology, May 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 21 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 26,459 followers.

Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials https://t.co/oIWSetMMWo https://t.co/Y8sm3Hbl40

16 May 2023

Reply Repost Favourite

RT @FrontOncology: New research: Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical…

12 May 2023

Reply Repost Favourite

RT @FrontOncology: New research: Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical…

12 May 2023

Reply Repost Favourite

New research: Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials: Energy-based focal therapy (FT) uses targeted, minimally invasive procedures to destroy tumors while preserving… #oncology https

12 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.